GLAXOSMITHKLINE LLC FDA Approval NDA 019151

NDA 019151

GLAXOSMITHKLINE LLC

FDA Drug Application

Application #019151

Documents

Letter2002-12-05
Letter2004-06-16
Letter2013-03-22
Review1997-12-23
Label2013-03-26
Label2018-11-02
Letter2018-11-07

Application Sponsors

NDA 019151GLAXOSMITHKLINE LLC

Marketing Status

Discontinued001
Discontinued002
Discontinued003

Application Products

001TABLET;ORAL150MG1RYTHMOLPROPAFENONE HYDROCHLORIDE
002TABLET;ORAL300MG1RYTHMOLPROPAFENONE HYDROCHLORIDE
003TABLET;ORAL225MG1RYTHMOLPROPAFENONE HYDROCHLORIDE

FDA Submissions

TYPE 1; Type 1 - New Molecular EntityORIG1AP1989-11-27STANDARD
EFFICACY; EfficacySUPPL2AP1997-12-23UNKNOWN
MANUF (CMC); Manufacturing (CMC)SUPPL3AP1993-11-23STANDARD
LABELING; LabelingSUPPL4AP1997-03-19STANDARD
LABELING; LabelingSUPPL5AP2002-12-05STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL6AP1999-09-24STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL7AP2000-07-14STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL8AP2000-12-21STANDARD
LABELING; LabelingSUPPL9AP2002-12-05STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL10AP2002-01-11STANDARD
LABELING; LabelingSUPPL12AP2013-03-20UNKNOWN
MANUF (CMC); Manufacturing (CMC)SUPPL13AP2014-07-11STANDARD
LABELING; LabelingSUPPL15AP2018-11-02STANDARD

Submissions Property Types

SUPPL1Null0
SUPPL3Null0
SUPPL6Null0
SUPPL7Null0
SUPPL8Null0
SUPPL10Null0
SUPPL12Null15
SUPPL13Null0
SUPPL15Null7

CDER Filings

GLAXOSMITHKLINE LLC
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 19151
            [companyName] => GLAXOSMITHKLINE LLC
            [docInserts] => ["",""]
            [products] => [{"drugName":"RYTHMOL","activeIngredients":"PROPAFENONE HYDROCHLORIDE","strength":"150MG","dosageForm":"TABLET;ORAL","marketingStatus":"Discontinued","te":"None","rld":"Yes","rs":"No"},{"drugName":"RYTHMOL","activeIngredients":"PROPAFENONE HYDROCHLORIDE","strength":"300MG","dosageForm":"TABLET;ORAL","marketingStatus":"Discontinued","te":"None","rld":"Yes","rs":"No"},{"drugName":"RYTHMOL","activeIngredients":"PROPAFENONE HYDROCHLORIDE","strength":"225MG","dosageForm":"TABLET;ORAL","marketingStatus":"Discontinued","te":"None","rld":"Yes","rs":"No"}]
            [labels] => [{"actionDate":"11\/02\/2018","submission":"SUPPL-15","supplementCategories":"Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2018\\\/019151s015lbl.pdf\"}]","notes":""},{"actionDate":"03\/20\/2013","submission":"SUPPL-12","supplementCategories":"Labeling-Patient Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2013\\\/019151s012lbl.pdf\"}]","notes":""}]
            [originalApprovals] => [{"actionDate":"RYTHMOL","submission":"PROPAFENONE HYDROCHLORIDE","actionType":"150MG","submissionClassification":"TABLET;ORAL","reviewPriority":"Discontinued","inserts":"[]","notes":">Yes"},{"actionDate":"RYTHMOL","submission":"PROPAFENONE HYDROCHLORIDE","actionType":"300MG","submissionClassification":"TABLET;ORAL","reviewPriority":"Discontinued","inserts":"[]","notes":">Yes"},{"actionDate":"RYTHMOL","submission":"PROPAFENONE HYDROCHLORIDE","actionType":"225MG","submissionClassification":"TABLET;ORAL","reviewPriority":"Discontinued","inserts":"[]","notes":">Yes"}]
            [supplements] => 
            [actionDate] => 2018-11-02
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.